JD Health International Inc. (HKG: 6618)
Hong Kong
· Delayed Price · Currency is HKD 28.75
+0.40 (1.41%)
Oct 10, 2024, 4:08 PM HKT
JD Health International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 54,764 | 53,530 | 46,736 | 30,682 | 19,383 | 10,842 | Upgrade
|
| Revenue Growth (YoY) | 2.13% | 14.54% | 52.32% | 58.30% | 78.77% | 32.72% | Upgrade
|
| Cost of Revenue | 42,401 | 41,665 | 36,845 | 23,485 | 14,465 | 8,030 | Upgrade
|
| Gross Profit | 12,362 | 11,865 | 9,892 | 7,197 | 4,917 | 2,812 | Upgrade
|
| Selling, General & Admin | 10,326 | 9,938 | 8,871 | 7,670 | 3,957 | 2,041 | Upgrade
|
| Research & Development | 1,255 | 1,226 | 1,067 | 892.91 | 609.07 | 338.24 | Upgrade
|
| Operating Expenses | 11,576 | 11,234 | 10,037 | 8,601 | 4,566 | 2,381 | Upgrade
|
| Operating Income | 786.62 | 630.85 | -145.12 | -1,404 | 351.6 | 431.58 | Upgrade
|
| Interest Expense | -9.12 | -9.49 | -9.1 | -6 | -3.42 | -35.5 | Upgrade
|
| Interest & Investment Income | 2,002 | 1,949 | 864.27 | 457.57 | 149.12 | 31.78 | Upgrade
|
| Earnings From Equity Investments | -79.37 | -70.76 | -96.76 | -94.17 | -77.02 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 601.24 | 193.71 | 82.52 | 145.15 | -17,492 | -1,263 | Upgrade
|
| Pretax Income | 3,301 | 2,693 | 695.81 | -901.49 | -17,072 | -834.7 | Upgrade
|
| Income Tax Expense | 686.2 | 550.47 | 312.58 | 171.33 | 162.76 | 137.11 | Upgrade
|
| Earnings From Continuing Operations | 2,615 | 2,143 | 383.23 | -1,073 | -17,235 | -971.81 | Upgrade
|
| Minority Interest in Earnings | 2.4 | -1.04 | -3.12 | -0.69 | 0.53 | - | Upgrade
|
| Net Income | 2,618 | 2,142 | 380.11 | -1,074 | -17,234 | -971.81 | Upgrade
|
| Net Income to Common | 2,618 | 2,142 | 380.11 | -1,074 | -17,234 | -971.81 | Upgrade
|
| Net Income Growth | 52.37% | 463.49% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 3,134 | 3,124 | 3,107 | 3,095 | 2,209 | 2,149 | Upgrade
|
| Shares Outstanding (Diluted) | 3,161 | 3,164 | 3,144 | 3,095 | 2,209 | 2,149 | Upgrade
|
| Shares Change (YoY) | 0.15% | 0.62% | 1.60% | 40.13% | 2.76% | - | Upgrade
|
| EPS (Basic) | 0.84 | 0.69 | 0.12 | -0.35 | -7.80 | -0.45 | Upgrade
|
| EPS (Diluted) | 0.84 | 0.68 | 0.12 | -0.35 | -7.80 | -0.45 | Upgrade
|
| EPS Growth | 54.42% | 466.67% | - | - | - | - | Upgrade
|
| Free Cash Flow | 6,436 | 4,544 | 5,865 | 2,929 | 3,684 | 404.28 | Upgrade
|
| Free Cash Flow Per Share | 2.04 | 1.44 | 1.87 | 0.95 | 1.67 | 0.19 | Upgrade
|
| Gross Margin | 22.57% | 22.17% | 21.16% | 23.46% | 25.37% | 25.94% | Upgrade
|
| Operating Margin | 1.44% | 1.18% | -0.31% | -4.58% | 1.81% | 3.98% | Upgrade
|
| Profit Margin | 4.78% | 4.00% | 0.81% | -3.50% | -88.92% | -8.96% | Upgrade
|
| Free Cash Flow Margin | 11.75% | 8.49% | 12.55% | 9.54% | 19.01% | 3.73% | Upgrade
|
| EBITDA | 945.98 | 794.92 | -60.93 | -1,372 | 364.5 | 436.88 | Upgrade
|
| EBITDA Margin | 1.73% | 1.48% | -0.13% | -4.47% | 1.88% | 4.03% | Upgrade
|
| D&A For EBITDA | 159.36 | 164.07 | 84.19 | 32.41 | 12.91 | 5.3 | Upgrade
|
| EBIT | 786.62 | 630.85 | -145.12 | -1,404 | 351.6 | 431.58 | Upgrade
|
| EBIT Margin | 1.44% | 1.18% | -0.31% | -4.58% | 1.81% | 3.98% | Upgrade
|
| Effective Tax Rate | 20.78% | 20.44% | 44.92% | - | - | - | Upgrade
|
| Advertising Expenses | - | 1,305 | 922.22 | 1,290 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.